InSysBio announces its collaboration with discoveric bio alpha

The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid.

CariGenetics launches Caribbean Genome Programme with Oxford Nanopore to drive regional genomic research

CariGenetics and Oxford Nanopore Technologies have launched the Caribbean Genome Programme, the first large-scale genomic sequencing initiative in the region. This pioneering effort is set to address unmet need in advancing regional genetic research in the Caribbean, providing real-time, high throughput sequencing to address critical health disparities, starting with men’s health.

InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities

InformedDNA has acquired Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. The combination significantly expands patient, provider and payor access to a broader range of genetic insights and enables more personalized, data-driven treatment and medication decisions for better outcomes and reduced healthcare costs.

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking pathologist workforce.

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

START's site network solidifies its global leadership in urological cancer trials.

Sirio Launches Global Research Institute for Longevity Studies [SIA]

Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer

Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

This press release highlights the recent ruling by the United States District Court for the Central District of California, which denied QIAGEN’s Partial Motion to Dismiss and, in the alternative, to stay counterclaims brought by Zymo Research, including claims of patent unenforceability and antitrust violations.

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

Sapio Sciences today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery.

Coronado Research Announce the Appointment of Stephen Ralston as EVP Market Access and HEOR

Coronado Research, a consultancy-led, professional services organisation providing support to pharmaceutical, biotechnology, and medical device companies, has appointed Stephen Ralston as EVP Market Access and Health Economics Outcomes Research (HEOR).

Coronado Research Announce the Appointment of Nick Littlebury as EVP, Regulatory Affairs

Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle.

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

The press release highlights the Quick-16S™ Full-Length Library Prep Kit, which offers the fastest, most streamlined full-length 16S library preparation workflow. With as little as 30 minutes of hands-on time, the kit prepares 96 samples while ensuring high-quality libraries. The kit is optimized for both PacBio® SMRTbell® and Kinnex™ library prep kits, and is fully compatible with ONT® platforms, making it a versatile solution for diverse sequencing applications. Additionally, the integrated qPCR dye provides real-time quality control to guarantee the highest standards for every library.

From Reshaping Newborn Screening to Redefining Longevity Science, Bio-IT World 2025 Will Highlight Transformative Applications of New Technologies

Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of distinguished biotech, pharmaceutical, and healthcare leaders who are harnessing new technologies to push therapeutic boundaries.

ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks

ClearNote Health announced an agreement with Claritev, Inc., (previously MultiPlan, Inc.) that will make ClearNote Health’s Avantect Pancreatic Cancer Test available to health plan members accessing Claritev’s national PHCS and MultiPlan Networks.

Watson-Marlow Fluid Technology Solutions to showcase single-use advancements in sustainability and supply agility at INTERPHEX 2025

Watson-Marlow Fluid Technology Solutions(WMFTS) will reveal its new WMArchitect Interchangeable Parts service as well as showcase new sustainability benefits for its users from advancements in BioClamp manufacturing at booth 2753 during INTERPHEX 2025, held from April 1st-3rd at the Javits Center in NYC, USA.

Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President, Integrated Drug Discovery; Jayadeva Sajankila as Vice President and Head, Chemical Development Solutions

Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare

Zymo Research Reaffirms Commitment to American Manufacturing

I’m reaching out from Zymo Research to share our latest press release highlighting our commitment to American manufacturing. With the majority of our products—including key components and materials—designed, manufactured, and assembled in Southern California, we are dedicated to delivering high-quality, reliable solutions to researchers worldwide. Given your focus on [Relevant Industry/Fields], we believe this announcement will be of great interest to your audience. Our USA-based operations not only ensure stringent quality control and supply chain stability but also allow us to maintain consistent pricing, even amidst evolving trade conditions.

Qureight and Remedy Cell partner to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

Qureight Ltd. and Remedy Cell are integrating the latest AI deep learning technology into a Phase 1b study of RC-0315, to develop a novel therapy for the fatal lung condition Idiopathic Pulmonary Fibrosis (IPF).

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD